Recombinant science, built to match the innovator and scale with the market.

Peptide biosimilars demand a different kind of precision.

Peptides are short chains of amino acids — structurally more complex than small molecules, yet more sensitive to the manufacturing process than large biologics. A peptide biosimilar must match the reference product not just in primary sequence, but in higher-order structure, solubility, purity profile and biological activity.

That precision starts with the expression system. Amogen's pipeline is built entirely on Saccharomyces cerevisiae recombinant fermentation — the same host system used by the innovators of semaglutide and insulin degludec. The result is a structural fidelity and regulatory alignment that synthetic SPPS routes cannot replicate, at a scale no other Indian manufacturer has achieved.